AliveCor, the global leader in AI-powered cardiology, today announced the activation of its services and solutions, designed specifically for the U.S. veterans, on the Veterans Affairs (VA) Federal ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first ...

Himplant, a leader in cosmetic penile enhancement, is pleased to highlight the publication of a comprehensive study titled ...

De minimis shipments, valued at $800 or less, are exempt from the rigorous oversight that applies to regular imports.

BEVERLY, Mass., Nov. 4, 2024 /PRNewswire/ -- Award-winning medical technology innovator, Quanta Dialysis Technologies®, has confirmed the US Food and Drug Administration (FDA) has given 510(k) ...

CytoDyn (CYDY) announced that it has received clearance from the FDA to commence its Phase II oncology trial. The study will evaluate the ...

EST Aligos Therapeutics (ALGS) trading halted, volatility trading pause Published first on TheFly – the ultimate source for ...

The FDA has begun traceback efforts, suggesting that investigators have identified some possible pathogen sources. However, the FDA has not reported what food it is tracing and has not begun on ...

Corin announced that it received FDA 510(k) clearance for its Icona femoral stem implant for total hip arthroplasty (THA).

Let there be green light: The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as being capable of improving a patient’s vision ...

Qiagen NV added to its growing roster of panels cleared by the U.S. FDA in 2024 with the agency’s nod for its Qiastat-Dx Meningitis/Encephalitis assay. The clearance validates Qiagen’s strategy of ...

Quanta Dialysis Technologies Ltd. received the greenlight from the U.S. FDA for the use of its portable dialysis system at home. The clearance brings a much-needed option for patients with end-stage ...